, Tracking Stock Market Picks
Enter Symbol:
Durata Therapeutics Inc. (DRTX) [hlAlert]

up 181.39 %

Durata Therapeutics Inc. (DRTX) rated Outperform by Credit Suisse

Posted on: Friday,  Mar 15, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Durata Therapeutics Inc. (NASDAQ: DRTX) on 03/15/2013. Previously Credit Suisse rated Outperform Durata Therapeutics Inc. (NASDAQ: DRTX) on
08/14/2012., when the stock price was $8.44. Since then, Durata Therapeutics Inc. has gained 181.40% as of 11/14/2014's recent price of $23.75.
If you would have followed the previous Credit Suisse's recommendation on DRTX, you would have gained 181.39% of your investment in 822 days.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/15/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  7.88 %
1 Month up  12.25 %
3 Months up  39.51 %
1 YTD up  59.42 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/14/2012 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy